Copyright Reports & Markets. All rights reserved.

Global and China Nanotechnology in Cancer Treatment Market 2020 by Company, Type and Application, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Product Overview and Scope of Nanotechnology in Cancer Treatment
    • 1.2 Classification of Nanotechnology in Cancer Treatment by Type
      • 1.2.1 Overview: Global Nanotechnology in Cancer Treatment Revenue by Type: 2015 Versus 2019 Versus 2025
      • 1.2.2 Global Nanotechnology in Cancer Treatment Revenue Market Share by Type in 2019
      • 1.2.3 Nanoparticles
      • 1.2.4 Nanorods
      • 1.2.5 Nanofibers
      • 1.2.6 Graphene
      • 1.2.7 Metal-Organic Frameworks
      • 1.2.8 Nanobiosensors
      • 1.2.9 Nanofluidic Devices
      • 1.2.10 Nanotools
    • 1.3 Global Nanotechnology in Cancer Treatment Market by Application
      • 1.3.1 Overview: Global Nanotechnology in Cancer Treatment Revenue by Application: 2015 Versus 2019 Versus 2025
      • 1.3.2 Cancer Detection
      • 1.3.3 Imaging
      • 1.3.4 Drug Delivery
      • 1.3.5 Radiotherapy
      • 1.3.6 Immunotherapy
      • 1.3.7 Phototherapy
    • 1.4 Global Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 1.5 Global Nanotechnology in Cancer Treatment Market Size by Regions: 2015 VS 2019 VS 2025
    • 1.6 Global Nanotechnology in Cancer Treatment Market Size by Regions (2015-2020)
    • 1.7 Global Nanotechnology in Cancer Treatment Market Size and Forecast by Regions (2020-2025)
      • 1.7.1 North America Nanotechnology in Cancer Treatment Status and Prospect (2015-2025)
      • 1.7.2 Europe Nanotechnology in Cancer Treatment Status and Prospect (2015-2025)
      • 1.7.3 Asia Nanotechnology in Cancer Treatment Status and Prospect (2015-2025)
      • 1.7.4 South America Nanotechnology in Cancer Treatment Status and Prospect (2015-2025)
      • 1.7.5 Middle East & Africa Nanotechnology in Cancer Treatment Status and Prospect (2015-2025)

    2 Company Profiles

    • 2.1 Abbott Laboratories
      • 2.1.1 Abbott Laboratories Details
      • 2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Abbott Laboratories SWOT Analysis
      • 2.1.4 Abbott Laboratories Product and Services
      • 2.1.5 Abbott Laboratories Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Nanosphere Inc.
      • 2.2.1 Nanosphere Inc. Details
      • 2.2.2 Nanosphere Inc. Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Nanosphere Inc. SWOT Analysis
      • 2.2.4 Nanosphere Inc. Product and Services
      • 2.2.5 Nanosphere Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Sigma-Tau Pharmaceuticals Inc.
      • 2.3.1 Sigma-Tau Pharmaceuticals Inc. Details
      • 2.3.2 Sigma-Tau Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Sigma-Tau Pharmaceuticals Inc. SWOT Analysis
      • 2.3.4 Sigma-Tau Pharmaceuticals Inc. Product and Services
      • 2.3.5 Sigma-Tau Pharmaceuticals Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Combimatrix Corporation
      • 2.4.1 Combimatrix Corporation Details
      • 2.4.2 Combimatrix Corporation Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Combimatrix Corporation SWOT Analysis
      • 2.4.4 Combimatrix Corporation Product and Services
      • 2.4.5 Combimatrix Corporation Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Merck & Company Inc.
      • 2.5.1 Merck & Company Inc. Details
      • 2.5.2 Merck & Company Inc. Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Merck & Company Inc. SWOT Analysis
      • 2.5.4 Merck & Company Inc. Product and Services
      • 2.5.5 Merck & Company Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 GE Healthcare
      • 2.6.1 GE Healthcare Details
      • 2.6.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 GE Healthcare SWOT Analysis
      • 2.6.4 GE Healthcare Product and Services
      • 2.6.5 GE Healthcare Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Celgene Corporation
      • 2.7.1 Celgene Corporation Details
      • 2.7.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Celgene Corporation SWOT Analysis
      • 2.7.4 Celgene Corporation Product and Services
      • 2.7.5 Celgene Corporation Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 Mallinckrodt Plc
      • 2.8.1 Mallinckrodt Plc Details
      • 2.8.2 Mallinckrodt Plc Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 Mallinckrodt Plc SWOT Analysis
      • 2.8.4 Mallinckrodt Plc Product and Services
      • 2.8.5 Mallinckrodt Plc Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Johnson & Johnson
      • 2.9.1 Johnson & Johnson Details
      • 2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Johnson & Johnson SWOT Analysis
      • 2.9.4 Johnson & Johnson Product and Services
      • 2.9.5 Johnson & Johnson Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Pfizer, Inc.
      • 2.10.1 Pfizer, Inc. Details
      • 2.10.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Pfizer, Inc. SWOT Analysis
      • 2.10.4 Pfizer, Inc. Product and Services
      • 2.10.5 Pfizer, Inc. Nanotechnology in Cancer Treatment Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    • 3.1 Global Nanotechnology in Cancer Treatment Market Size by Players (2015-2020)
    • 3.2 China Nanotechnology in Cancer Treatment Market Size by Players (2015-2020)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 5 Nanotechnology in Cancer Treatment Players Market Share
      • 3.3.2 Top 10 Nanotechnology in Cancer Treatment Players Market Share

    4 North America Market Size and Forecast by Countries

    • 4.1 North America Nanotechnology in Cancer Treatment Market Size by Countries (2015-2020)
    • 4.2 North America Nanotechnology in Cancer Treatment Market Size and Forecast by Countries (2015-2026)
    • 4.3 United States Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 4.4 Canada Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 4.5 Mexico Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)

    5 Europe Market Size and Forecast by Countries

    • 5.1 Europe Nanotechnology in Cancer Treatment Market Size by Countries (2015-2020)
    • 5.2 Europe Nanotechnology in Cancer Treatment Market Size and Forecast by Countries (2015-2026)
    • 5.3 Germany Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 5.4 France Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 5.5 UK Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 5.6 Russia Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 5.7 Italy Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)

    6 Asia-Pacific Market Size and Forecast by Countries

    • 6.1 Asia-Pacific Nanotechnology in Cancer Treatment Market Size by Regions (2015-2020)
    • 6.2 Asia-Pacific Nanotechnology in Cancer Treatment Market Size and Forecast by Regions (2015-2026)
    • 6.3 China Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 6.4 Japan Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 6.5 Korea Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 6.6 India Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 6.7 Southeast Asia Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)

    7 South America Market Size and Forecast by Countries

    • 7.1 South America Nanotechnology in Cancer Treatment Market Size by Countries (2015-2020)
    • 7.2 South America Nanotechnology in Cancer Treatment Market Size and Forecast by Countries (2015-2026)
    • 7.3 Brazil Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 7.4 Argentina Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)

    8 Middle East & Africa Market Size and Forecast by Countries

    • 8.1 Middle East & Africa Nanotechnology in Cancer Treatment Revenue by Regions (2015-2020)
    • 8.2 Middle East & Africa Nanotechnology in Cancer Treatment Market Size and Forecast by Countries (2015-2026)
    • 8.3 Saudi Arabia Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 8.4 UAE Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 8.5 Egypt Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)
    • 8.6 South Africa Nanotechnology in Cancer Treatment Market Size and Forecast (2015-2025)

    9 Market Size Segment by Type

    • 9.1 Global Nanotechnology in Cancer Treatment Market Size and Forecast by Type (2015-2025)
      • 9.1.1 Global Nanotechnology in Cancer Treatment Market Size by Type (2015-2020)
      • 9.1.2 Global Nanotechnology in Cancer Treatment Market Size Forecast by Type (2020-2025)
    • 9.2 China Nanotechnology in Cancer Treatment Market Size and Forecast by Type (2015-2025)
      • 9.2.1 China Nanotechnology in Cancer Treatment Market Size by Type (2015-2020)
      • 9.2.2 China Nanotechnology in Cancer Treatment Market Size Forecast by Type (2020-2025)

    10 Market Size Segment by Application

    • 10.1 Global Nanotechnology in Cancer Treatment Market Size and Forecast by Application (2015-2025)
      • 10.1.1 Global Nanotechnology in Cancer Treatment Market Size by Application (2015-2020)
      • 10.1.2 Global Nanotechnology in Cancer Treatment Market Size Forecast by Application (2020-2025)
    • 10.2 China Nanotechnology in Cancer Treatment Market Size and Forecast by Application (2015-2025)
      • 10.2.1 China Nanotechnology in Cancer Treatment Market Size by Application (2015-2020)
      • 10.2.2 China Nanotechnology in Cancer Treatment Market Size Forecast by Application (2020-2025)

    11 Research Findings and Conclusion

      12 Appendix

      • 12.1 Methodology
      • 12.2 Data Source
      • 12.3 Disclaimer

      Market Overview
      The global Nanotechnology in Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

      The Nanotechnology in Cancer Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

      Market segmentation
      Nanotechnology in Cancer Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

      Breakdown by Type, Nanotechnology in Cancer Treatment market has been segmented into Nanoparticles, Nanorods, Nanofibers, Graphene, Metal-Organic Frameworks, Nanobiosensors, Nanofluidic Devices, Nanotools, etc.

      Breakdown by Application, Nanotechnology in Cancer Treatment has been segmented into Cancer Detection, Imaging, Drug Delivery, Radiotherapy, Immunotherapy, Phototherapy, etc.

      Regions and Countries Level Analysis
      Regional analysis is another highly comprehensive part of the research and analysis study of the global Nanotechnology in Cancer Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Nanotechnology in Cancer Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nanotechnology in Cancer Treatment market.

      For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

      Competitive Landscape and Nanotechnology in Cancer Treatment Market Share Analysis
      Nanotechnology in Cancer Treatment competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Nanotechnology in Cancer Treatment revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nanotechnology in Cancer Treatment revenue and market share for each player covered in this report.

      The major players covered in Nanotechnology in Cancer Treatment are: Abbott Laboratories, Nanosphere Inc., Sigma-Tau Pharmaceuticals Inc., Combimatrix Corporation, Merck & Company Inc., GE Healthcare, Celgene Corporation, Mallinckrodt Plc, Johnson & Johnson, Pfizer, Inc., etc. Among other players domestic and global, Nanotechnology in Cancer Treatment market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

      Market segment by players, this report covers
      Abbott Laboratories
      Nanosphere Inc.
      Sigma-Tau Pharmaceuticals Inc.
      Combimatrix Corporation
      Merck & Company Inc.
      GE Healthcare
      Celgene Corporation
      Mallinckrodt Plc
      Johnson & Johnson
      Pfizer, Inc.

      Market segment by regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
      South America (Brazil, Argentina)
      MENA (Saudi Arabia, UAE, Turkey and South Africa)

      Market segment by Type, covers:
      Nanoparticles
      Nanorods
      Nanofibers
      Graphene
      Metal-Organic Frameworks
      Nanobiosensors
      Nanofluidic Devices
      Nanotools

      Market segment by Application, can be divided into
      Cancer Detection
      Imaging
      Drug Delivery
      Radiotherapy
      Immunotherapy
      Phototherapy
      Buy now